Shah Neha, Crowell Trevor A, Hern Jaclyn, Anyebe Victor, Bahemana Emmanuel, Kibuuka Hannah, Singoei Valentine, Maswai Jonah, Parikh Ajay, Duff Emma R, Cavanaugh Joseph Sean, Romo Matthew L, Ake Julie A, Reid Michael J A, Nkengasong Amb John N
U.S. Military HIV Research Program, Center of Infectious Disease Research, Walter Reed Army Institute of Research, Silver Spring, Maryland.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland.
Am J Trop Med Hyg. 2024 Oct 29;112(1):45-55. doi: 10.4269/ajtmh.24-0249. Print 2025 Jan 8.
Over the last 20 years, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) has rapidly expanded and made remarkable progress toward the UNAIDS 95-95-95 targets to end the HIV epidemic. Nevertheless, HIV continues to pose a significant health challenge globally, with a particular impact on the African continent. Funded by PEPFAR, the African Cohort Study (AFRICOS) has served as a monitoring and evaluation tool for PEPFAR to help guide HIV policy and PEPFAR programming for the last 10 years since its inception and offers a compelling example of how PEPFAR's investment in science continues to reap dividends. This paper details and critically reviews the transformative research AFRICOS has had on helping to end the HIV epidemic as a public health threat by 2030.
在过去20年里,美国总统艾滋病紧急救援计划(PEPFAR)迅速扩大,并在实现联合国艾滋病规划署提出的到2030年终结艾滋病流行的95-95-95目标方面取得了显著进展。尽管如此,艾滋病毒在全球范围内仍然构成重大的健康挑战,对非洲大陆的影响尤为严重。由PEPFAR资助的非洲队列研究(AFRICOS)自成立以来的10年里,一直作为PEPFAR的监测和评估工具,以帮助指导艾滋病政策和PEPFAR项目规划,它提供了一个令人信服的例子,说明PEPFAR在科学方面的投资如何持续产生效益。本文详细介绍并批判性地审视了AFRICOS在帮助到2030年将艾滋病毒作为公共卫生威胁终结方面所进行的变革性研究。